BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28723548)

  • 1. The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.
    Dai HS; Griffin N; Bolyard C; Mao HC; Zhang J; Cripe TP; Suenaga T; Arase H; Nakano I; Chiocca EA; Kaur B; Yu J; Caligiuri MA
    Immunity; 2017 Jul; 47(1):159-170.e10. PubMed ID: 28723548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
    J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains.
    Johansson PJ; Schröder AK; Nardella FA; Mannik M; Christensen P
    Immunology; 1986 Jun; 58(2):251-5. PubMed ID: 3011655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.
    Oakes JE; Lausch RN
    Infect Immun; 1981 Jul; 33(1):109-14. PubMed ID: 6266961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted processing of CD16a/Fc γ receptor IIIa
    Patel KR; Roberts JT; Subedi GP; Barb AW
    J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Basis for the Recognition of Herpes Simplex Virus Type 1 Infection by Human Natural Killer Cells.
    Dai HS; Caligiuri MA
    Front Immunol; 2018; 9():183. PubMed ID: 29483911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis.
    McKendall RR
    J Infect Dis; 1985 Mar; 151(3):464-70. PubMed ID: 2982965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin.
    Johnson DC; Feenstra V
    J Virol; 1987 Jul; 61(7):2208-16. PubMed ID: 3035221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.
    Moraru M; Black LE; Muntasell A; Portero F; López-Botet M; Reyburn HT; Pandey JP; Vilches C
    J Immunol; 2015 Aug; 195(4):1676-84. PubMed ID: 26179905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors.
    Corrales-Aguilar E; Trilling M; Reinhard H; Mercé-Maldonado E; Widera M; Schaal H; Zimmermann A; Mandelboim O; Hengel H
    J Immunol Methods; 2013 Jan; 387(1-2):21-35. PubMed ID: 23023090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.
    Dubin G; Basu S; Mallory DL; Basu M; Tal-Singer R; Friedman HM
    J Virol; 1994 Apr; 68(4):2478-85. PubMed ID: 7511171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.
    Nagashunmugam T; Lubinski J; Wang L; Goldstein LT; Weeks BS; Sundaresan P; Kang EH; Dubin G; Friedman HM
    J Virol; 1998 Jul; 72(7):5351-9. PubMed ID: 9620988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of regions of herpes simplex virus type 1 glycoprotein E involved in binding the Fc domain of monomeric IgG and in forming a complex with glycoprotein I.
    Basu S; Dubin G; Basu M; Nguyen V; Friedman HM
    J Immunol; 1995 Jan; 154(1):260-7. PubMed ID: 7995945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species.
    Johansson PJ; Myhre EB; Blomberg J
    J Virol; 1985 Nov; 56(2):489-94. PubMed ID: 2997471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells.
    Kohl S; Sigouroudinia M; Engleman EG
    Pediatr Res; 1999 Dec; 46(6):755-9. PubMed ID: 10590035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
    Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
    Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.